Page last updated: 2024-08-25

clarithromycin and Arteriosclerosis, Coronary

clarithromycin has been researched along with Arteriosclerosis, Coronary in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (30.00)	29.6817
2010's	5 (50.00)	24.3611
2020's	2 (20.00)	2.80

Authors

Authors	Studies
Lee, TH; Liao, PC; Lin, CK; Lin, CL	1
Ärnlöv, J; Gluud, C; Harutyunyan, M; Hilden, J; Jakobsen, JC; Jensen, GB; Johansen, JS; Kastrup, J; Kjøller, E; Larsson, A; Sajadieh, A; Schroder, J; Winkel, P	1
Bjerre, M; Flyvbjerg, A; Gluud, C; Hansen, JF; Hilden, J; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Skoog, M; Winkel, P	1
Gluud, C; Hansen, JF; Hilden, J; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Lindschou, J; Skoog, M; Winkel, P	1
Li, C; Li, X; Liu, G; Wang, M; Wang, Z; Zhou, L	1
Fischer Hansen, J; Gluud, C; Hildebrandt, P; Hilden, J; Jensen, GB; Jespersen, CM; Kastrup, J; Kjøller, E; Kolmos, HJ; Winkel, P	1
Berg, HF; Kluytmans, JA; Maraha, B; Peeters, MF; Scheffer, GJ	1
Muhlestein, JB	1

Reviews

1 review(s) available for clarithromycin and Arteriosclerosis, Coronary

Article	Year
Antibiotic treatment of atherosclerosis. Current opinion in lipidology, 2003, Volume: 14, Issue:6 Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome	2003

Article

Year

Antibiotic treatment of atherosclerosis.

Current opinion in lipidology, 2003, Volume: 14, Issue:6

Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome

2003

Trials

3 trial(s) available for clarithromycin and Arteriosclerosis, Coronary

Article	Year
Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease. Journal of the American Heart Association, 2020, 03-03, Volume: 9, Issue:5 Topics: Aged; Anti-Bacterial Agents; Biomarkers; C-Reactive Protein; Chitinase-3-Like Protein 1; Clarithromycin; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Rate	2020
Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial. International journal of cardiology, 2015, Mar-01, Volume: 182 Topics: Aged; Anti-Bacterial Agents; Cause of Death; Clarithromycin; Coronary Artery Disease; Denmark; Female; Follow-Up Studies; Forecasting; Humans; Male; Morbidity; Retrospective Studies; Single-Blind Method; Stroke	2015
Effect of clarithromycin on inflammatory markers in patients with atherosclerosis. Clinical and diagnostic laboratory immunology, 2003, Volume: 10, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; C-Reactive Protein; Clarithromycin; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Middle Aged; Prospective Studies; Receptors, Interleukin-2; Treatment Failure; Tumor Necrosis Factor-alpha	2003

Other Studies

6 other study(ies) available for clarithromycin and Arteriosclerosis, Coronary

Article	Year
Cardiac events after using clarithromycin for anti-Helicobacter pylori therapy in patients with coronary artery disease. Medicine, 2023, Nov-10, Volume: 102, Issue:45 Topics: Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Retrospective Studies	2023
Clarithromycin in patients with coronary artery disease. The Medical letter on drugs and therapeutics, 2018, 05-21, Volume: 60, Issue:1547 Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacterial Infections; Clarithromycin; Coronary Artery Disease; Humans; Risk Factors	2018
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. Scandinavian journal of clinical and laboratory investigation, 2014, Volume: 74, Issue:8 Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Osteoprotegerin; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors	2014
Macrolides use and the risk of sudden cardiac death. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:6 Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Coronary Artery Disease; Coronary Disease; Death, Sudden, Cardiac; Erythromycin; Humans; Macrolides; Plaque, Atherosclerotic; Risk Factors; Torsades de Pointes	2016
Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective? Cardiology, 2011, Volume: 118, Issue:1 Topics: Anti-Bacterial Agents; Clarithromycin; Coronary Artery Disease; Death, Sudden, Cardiac; Denmark; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized Controlled Trials as Topic	2011
Antibiotics for heart health? Health news (Waltham, Mass.), 2002, Volume: 8, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; Chest Pain; Clarithromycin; Coronary Artery Disease; Humans; Inflammation	2002